Transphorm Inc (TGAN)

CEO:
Mario A. Rivas
Employees:
110
75 CASTILIAN DRIVE, GOLETA, CA, 93117
805-456-1300

Transphorm, Inc. develops, manufactures, and sells gallium nitride (GaN) semiconductor components used in power conversion in Mainland China, Hong Kong, Taiwan, the United States, Japan, South Korea, and Europe. Its GaN devices allows customers to design smaller, lighter, and cooler power systems creating increased functional value in end products, including smartphone power adapters/fast-chargers, power supplies for datacenter servers/communication, industrial power converters, and chargers/converters/inverters for electric vehicles. The company offers its products through sales representatives and distributors. Transphorm, Inc. headquartered in Goleta, California.

Data derived from most recent annual or quarterly report
Market Cap 180.925 Million Shares Outstanding61.961 Million Avg 30-day Volume 59.376 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.1
Price to Revenue7.3058 Debt to Equity0.0 EBITDA-28.751 Million
Price to Book Value5.7291 Operating Margin-169.6523 Enterprise Value129.576 Million
Current Ratio2.629 EPS Growth0 Quick Ratio1.286
1 Yr BETA 1.6129 52-week High/Low 5.9 / 1.94 Profit Margin-182.0756
Operating Cash Flow Growth0.0 Free Cash Flow to Firm (FCFF) TTM 0 Free Cash Flow to Equity (FCFE) TTM-25.514 Million
Altman Z-Score-3.593
Earnings Report2024-02-14

View recent insider trading info

Transphorm Inc YCharts
Yahoo! Finance finviz

Funds Holding TGAN (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding TGAN

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

15.4 Thousand total shares from 5 transactions

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

MCFARLAND KATHARINA G.

  • Director
 86,208 2023-11-22 5

SMALES KELLY

  • Director
 79,633 2023-11-22 5

MISHRA UMESH CHIEF TECHNOLOGY OFFICER

  • Officer
  • Director
 363,110 2023-11-17 6

PARIKH PRIMIT PRESIDENT AND CEO

  • Officer
  • Director
 502,090 2023-11-17 6

MCAULAY CAMERON CHIEF FINANCIAL OFFICER

  • Officer
 187,698 2023-11-17 5

MORELAND CYNTHIA J

  • Director
 80,028 2023-10-20 2

HUMPHREYS MICHAEL JULIAN

  • Director
 88,231 2023-10-20 3

KKR PHORM INVESTORS L.P.

KKR PHORM INVESTORS GP LLC

KKR GROUP PARTNERSHIP L.P.

KKR GROUP HOLDINGS CORP.

KKR GROUP CO. INC.

KKR & CO. INC.

KKR MANAGEMENT LLP

KRAVIS HENRY R

ROBERTS GEORGE R

  • 10% Owner
 24,411,968 2023-07-21 1

RIVAS MARIO CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
 122,213 2023-01-01 1

KKR GROUP PARTNERSHIP L.P.

KKR GROUP HOLDINGS CORP.

KKR & CO. INC.

KKR MANAGEMENT LLP

KRAVIS HENRY R

ROBERTS GEORGE R

  • 10% Owner
 21,175,980 2020-09-30 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

SMALES KELLY - Director

2023-11-27 20:24:34 -0500 2023-11-22 S 3,995 $2.63 d 79,633 direct yes 0.0 0.0 6.1644 3 0.0 1

MCFARLAND KATHARINA G. - Director

2023-11-27 20:23:53 -0500 2023-11-22 S 3,995 $2.70 d 86,208 direct yes 0.0 0.0 6.1644 3 0.0 1

SMALES KELLY - Director

2023-11-21 16:31:34 -0500 2023-11-20 S 656 $2.89 d 83,628 direct yes 2.8881 11.9134 11.9134 6 0.0 1

MCFARLAND KATHARINA G. - Director

2023-11-21 16:34:54 -0500 2023-11-20 S 3,515 $3.01 d 90,203 direct yes 2.8881 11.9134 11.9134 6 0.0 1

SMALES KELLY - Director

2023-11-21 16:31:34 -0500 2023-11-17 S 3,227 $2.82 d 84,284 direct yes 2.8881 11.9134 11.9134 6 0.0 1

PARIKH PRIMIT - Director - Officer PRESIDENT AND CEO

2023-11-21 16:32:26 -0500 2023-11-17 F 8,069 $2.77 d 502,090 direct 2.8881 11.9134 11.9134 6 0.0 1

MISHRA UMESH - Director - Officer CHIEF TECHNOLOGY OFFICER

2023-11-21 16:33:37 -0500 2023-11-17 F 1,614 $2.77 d 363,110 direct 2.8881 11.9134 11.9134 6 0.0 1

MCAULAY CAMERON - Officer CHIEF FINANCIAL OFFICER

2023-11-21 16:34:06 -0500 2023-11-17 F 2,536 $2.77 d 187,698 direct 2.8881 11.9134 11.9134 6 0.0 1

MORELAND CYNTHIA J - Director

2023-10-24 16:14:52 -0400 2023-10-20 A 2,083 a 80,028 direct -2.4793 3.3058 7.8512 5 -4.1322 3

SMALES KELLY - Director

2023-10-24 16:15:32 -0400 2023-10-20 A 2,708 a 87,511 direct -2.4793 3.3058 7.8512 5 -4.1322 3

MCFARLAND KATHARINA G. - Director

2023-10-24 16:14:19 -0400 2023-10-20 A 4,791 a 93,718 direct -2.4793 3.3058 7.8512 5 -4.1322 3

HUMPHREYS MICHAEL JULIAN - Director

2023-10-24 16:13:46 -0400 2023-10-20 A 2,812 a 88,231 direct -2.4793 3.3058 7.8512 5 -4.1322 3

HUMPHREYS MICHAEL JULIAN - Director

2023-10-13 16:22:30 -0400 2023-10-11 A 3,082 a 85,419 direct 4.4843 13.0045 30.9417 32.287 26 0.0 1

SMALES KELLY - Director

2023-10-13 16:24:54 -0400 2023-10-11 A 45,662 a 81,835 direct 4.4843 13.0045 30.9417 32.287 26 0.0 1

SMALES KELLY - Director

2023-10-13 16:24:54 -0400 2023-10-11 A 2,968 a 84,803 direct 4.4843 13.0045 30.9417 32.287 26 0.0 1

MORELAND CYNTHIA J - Director

2023-10-13 16:23:59 -0400 2023-10-11 A 45,662 a 75,662 direct 4.4843 13.0045 30.9417 32.287 26 0.0 1

MORELAND CYNTHIA J - Director

2023-10-13 16:23:59 -0400 2023-10-11 A 2,283 a 77,945 direct 4.4843 13.0045 30.9417 32.287 26 0.0 1

MCFARLAND KATHARINA G. - Director

2023-10-13 16:23:15 -0400 2023-10-11 A 45,662 a 83,676 direct 4.4843 13.0045 30.9417 32.287 26 0.0 1

MCFARLAND KATHARINA G. - Director

2023-10-13 16:23:15 -0400 2023-10-11 A 5,251 a 88,927 direct 4.4843 13.0045 30.9417 32.287 26 0.0 1

HUMPHREYS MICHAEL JULIAN - Director

2023-10-13 16:22:30 -0400 2023-10-11 A 45,662 a 82,337 direct 4.4843 13.0045 30.9417 32.287 26 0.0 1

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
TRANSPHORM INC TGAN 2023-12-06 21:45:04 UTC 1.794 3.526 100000
TRANSPHORM INC TGAN 2023-12-06 21:15:05 UTC 1.794 3.526 100000
TRANSPHORM INC TGAN 2023-12-06 20:45:03 UTC 1.794 3.526 100000
TRANSPHORM INC TGAN 2023-12-06 20:15:04 UTC 1.794 3.526 100000
TRANSPHORM INC TGAN 2023-12-06 19:45:04 UTC 1.794 3.526 100000
TRANSPHORM INC TGAN 2023-12-06 19:15:04 UTC 1.794 3.526 100000
TRANSPHORM INC TGAN 2023-12-06 18:45:03 UTC 1.794 3.526 100000
TRANSPHORM INC TGAN 2023-12-06 18:15:03 UTC 1.794 3.526 100000
TRANSPHORM INC TGAN 2023-12-06 17:45:03 UTC 1.794 3.526 100000
TRANSPHORM INC TGAN 2023-12-06 17:15:04 UTC 1.794 3.526 100000
TRANSPHORM INC TGAN 2023-12-06 16:45:04 UTC 1.794 3.526 100000
TRANSPHORM INC TGAN 2023-12-06 16:15:04 UTC 1.794 3.526 100000
TRANSPHORM INC TGAN 2023-12-06 15:45:03 UTC 1.794 3.526 100000
TRANSPHORM INC TGAN 2023-12-06 15:15:04 UTC 1.794 3.526 100000
TRANSPHORM INC TGAN 2023-12-06 14:45:04 UTC 1.831 3.489 100000
TRANSPHORM INC TGAN 2023-12-06 14:15:04 UTC 1.831 3.489 100000
TRANSPHORM INC TGAN 2023-12-06 13:45:04 UTC 2.0534 3.2666 55000
TRANSPHORM INC TGAN 2023-12-06 13:15:04 UTC 2.0534 3.2666 55000
TRANSPHORM INC TGAN 2023-12-05 22:15:04 UTC 2.0534 3.2666 100000
TRANSPHORM INC TGAN 2023-12-05 21:45:04 UTC 2.0534 3.2666 100000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund TGAN -100.0 shares, $-222.0 2023-09-30 N-PORT

No recent transactions

*** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

WhaleWisdom Logo

Elevate your investments